Literature DB >> 19762282

Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.

Giuseppe Murdaca1, Paola Contini, Maurizio Setti, Paola Cagnati, Francesca Lantieri, Francesco Indiveri, Francesco Puppo.   

Abstract

We have reported that serum level of soluble HLA-A, -B, -C (sHLA-A,-B,-C) antigens is elevated in HIV-infected subjects and decreases after antiretroviral therapy (HAART). In this study, we measured the levels of soluble HLA-G (sHLA-G) antigens in a cohort of HIV-infected patients before and during HAART. sHLA-G and sHLA-A, -B, -C levels were significantly elevated in HIV-infected subjects as compared with controls before antiretroviral treatment and significantly decreased after 36 months of HAART. sHLA-G levels were correlated with sHLA-A, -B, -C levels, the decrease of plasma HIV-RNA level, the increase of CD4+ T-lymphocyte number and the decrease of CD8+ T-lymphocyte number. These results suggest that the measurement of sHLA-G and sHLA-A, -B, -C antigen serum levels might represent a useful surrogate marker to monitor virological response and immune reconstitution in HIV-positive subjects undergoing HAART treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19762282     DOI: 10.1016/j.clim.2009.08.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  15 in total

1.  Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy.

Authors:  Giuseppe Murdaca; Paola Contini; Paola Cagnati; Simona Marenco; Giulia Pieri; Francesca Lantieri; Antonino Picciotto; Francesco Puppo
Journal:  Clin Exp Med       Date:  2015-11-14       Impact factor: 3.984

2.  Evaluation of membrane-bound and soluble forms of human leucocyte antigen-G in systemic sclerosis.

Authors:  P Contini; S Negrini; G Murdaca; M Borro; F Puppo
Journal:  Clin Exp Immunol       Date:  2018-05-23       Impact factor: 4.330

3.  Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.

Authors:  V Jucaud; M H Ravindranath; P I Terasaki; L E Morales-Buenrostro; F Hiepe; T Rose; R Biesen
Journal:  Clin Exp Immunol       Date:  2015-12-16       Impact factor: 4.330

4.  Evolution of the levels of human leukocyte antigen G (HLA-G) in Beninese infant during the first year of life in a malaria endemic area: using latent class analysis.

Authors:  Tania C d'Almeida; Ibrahim Sadissou; Gilles Cottrell; Rachida Tahar; Philippe Moreau; Benoit Favier; Kabirou Moutairou; Eduardo A Donadi; Achille Massougbodji; Nathalie Rouass-Freiss; David Courtin; André Garcia
Journal:  Malar J       Date:  2016-02-09       Impact factor: 2.979

Review 5.  Immunoregulatory Role of HLA-G in Allergic Diseases.

Authors:  Giuseppe Murdaca; Paola Contini; Simone Negrini; Giorgio Ciprandi; Francesco Puppo
Journal:  J Immunol Res       Date:  2016-06-20       Impact factor: 4.818

Review 6.  Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection.

Authors:  Angelique Hölzemer; Wilfredo F Garcia-Beltran; Marcus Altfeld
Journal:  Front Immunol       Date:  2017-11-14       Impact factor: 7.561

Review 7.  HLA-G/C, miRNAs, and their role in HIV infection and replication.

Authors:  Fulvio Celsi; Eulalia Catamo; Giulio Kleiner; Paola Maura Tricarico; Josef Vuch; Sergio Crovella
Journal:  Biomed Res Int       Date:  2013-06-13       Impact factor: 3.411

Review 8.  Immunomodulatory properties of HLA-G in infectious diseases.

Authors:  Laurence Amiot; Nicolas Vu; Michel Samson
Journal:  J Immunol Res       Date:  2014-04-15       Impact factor: 4.818

9.  Recipient HLA-G +3142 CC Genotype and Concentrations of Soluble HLA-G Impact on Occurrence of CMV Infection after Living-Donor Kidney Transplantation.

Authors:  Hana Guberina; Rafael Tomoya Michita; Sebastian Dolff; Anja Bienholz; Mirko Trilling; Falko M Heinemann; Peter A Horn; Andreas Kribben; Oliver Witzke; Vera Rebmann
Journal:  Int J Mol Sci       Date:  2017-11-05       Impact factor: 5.923

10.  Variation sites at the HLA-G 3' untranslated region confer differential susceptibility to HIV/HPV co-infection and aneuploidy in cervical cell.

Authors:  Fernanda Silva Medeiros; Albert Eduardo Silva Martins; Renan Garcia Gomes; Sávio Augusto Vieira de Oliveira; Stefan Welkovic; Magda Maruza; Maria Luiza Bezerra Menezes; Ricardo Arraes de Alencar Ximenes; George Tadeu Nunes Diniz; Eduardo Antônio Donadi; Norma Lucena-Silva
Journal:  PLoS One       Date:  2018-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.